According to Celldex Therapeutics's latest financial reports the company's current revenue (TTM) is $6.88 M. In 2022 the company made a revenue of $2.35 M a decrease over the years 2021 revenue that were of $4.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $6.88 M | 192.02% |
2022 | $2.35 M | -49.33% |
2021 | $4.65 M | -37.28% |
2020 | $7.41 M | 107.58% |
2019 | $3.57 M | -62.53% |
2018 | $9.53 M | -25.17% |
2017 | $12.74 M | 87.81% |
2016 | $6.78 M | 23.79% |
2015 | $5.48 M | 52.84% |
2014 | $3.58 M | -12.77% |
2013 | $4.11 M | -63.3% |
2012 | $11.2 M | 20.91% |
2011 | $9.26 M | -80.2% |
2010 | $46.79 M | 208.25% |
2009 | $15.18 M | 103.61% |
2008 | $7.45 M | 171.9% |
2007 | $2.74 M | -44.39% |
2006 | $4.93 M | 59.67% |
2005 | $3.08 M | -54.97% |
2004 | $6.85 M | 48.04% |
2003 | $4.63 M | -30.9% |
2002 | $6.7 M | 100.39% |
2001 | $3.34 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 849,776.51% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 409,459.78% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 549,791.70% | ๐ฌ๐ง UK |
Titan Pharmaceuticals
TTNP | $0 M | -99.99% | ๐บ๐ธ USA |
Seagen
SGEN | $2.30 B | 33,320.76% | ๐บ๐ธ USA |
Agenus
AGEN | $0.15 B | 2,171.00% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $1.02 B | 14,774.33% | ๐บ๐ธ USA |